SCIENCE IN SPORT PLC

Major Shareholding Notification • May 2, 2025

National Storage Mechanism | Additional information

RNS Number : 2344H

Science in Sport PLC

02 May 2025

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:	Science in Sport plc ("SiS")
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree	Science in sport plc
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:      The latest practicable date prior to the disclosure	2 May 2025
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"	N/A

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
	Interests		Short positions
Number	%	Number	%
(1) Relevant securities owned and/or controlled:	Nil	0	Nil	0
(2) Cash-settled derivatives:	Nil	0	Nil	0
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	Nil	0	Nil	0
TOTAL:	Nil	0	Nil	0

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:	N/A
Details, including nature of the rights concerned and relevant percentages:	N/A

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(a)  Interests held by the directors of Science in Sport plc, their close relatives and related trusts (excluding share awards set out in (b) below):

Name	Job Title	Number of ordinary shares	Percentage of existing issued share capital
Gomrath Ltd	Company Controlled by Daniel P Wright	6,882,352	2.96
Mr Daniel P Wright	Executive Chairman	1,319,141	0.57
Mr Roger T Mather	Non-Executive Director	224,437	0.10
Mr Chris Welsh	Chief Financial Officer	208,284	0.09
Mr Daniel Lampard	Chief Operating Officer	33,333	0.01

(b)  Options and awards granted under Science in Sport plc's share plans held by the directors of Science in Sport plc:

Name	Date of grant of right	Number of SiS Subsidiary Shares owned	Number of SiS Shares that may be acquired**	Normal vesting date
Daniel Wright*	5 July 2024	5,882,353 B ordinary shares 3,501,946 C ordinary shares	4,494,617	5 July 2027
Chris Welsh	5 July 2024	2,178,988 C ordinary shares	2,005,062	5 July 2027
Daniel Lampard	5 July 2024	2,714,932 B ordinary shares 2,334,630 C ordinary shares	2,735,520	5 July 2027

* This includes the rights held by the Elidor Trust.

** The number of SiS Shares that may be acquired as consideration for the transfer of the relevant SiS Subsidiary Shares to the Company on or around the time of the Acquisition has been determined by the SiS Remuneration Committee in accordance with the articles of association of the SiS Subsidiary and the terms of the Subsidiary Put and Call Options

(c) Interests held by employee benefit trusts

Name	Number of Shares Held	% of ISC
Science in Sport EBT	1,694,395	0.73

(d) Ordinary shares of 0.1 pence each in Science in Sport plc held by connected advisers of Science in Sport plc on a non-exempt basis

Financial adviser	Number of ordinary shares	Number of warrants
N/A	N/A	N/A

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
N/A

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
N/A

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

###### Date of disclosure:	2 May 2025
###### Contact name:	Chris Welsh
###### Telephone number:	+44 (0) 20 7400 3700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEESSMSAEEISESI